The Synthetic Biology Innovation Network

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Synthetic biology sells picks and shovels for the $4 trillion bioeconomy, and Codon Capital sees this opportunity.

Automated Biology Is Now an Affordable Reality

How printed circuit boards and off-the-shelf components can automate biological experiments.

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

Search funds could be a powerful accelerant to bring the tools of synthetic biology to a wider audience, bringing about the promise of synbio to previously untouched fields.

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Often compared, Ginkgo Bioworks and Zymergen are differentiated by technology stack and business approach

Featured

COVID-19 Resources

SynBioBeta is proud to partner with Leaps by Bayer to make a visual timeline for COVID-19 treatment and prevention. The scientific community is working around the clock, not only to protect us from COVID-19, but to...

Editors' picks

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Synthetic biology sells picks and shovels for the $4 trillion bioeconomy, and Codon Capital sees this opportunity. Its investments are a who’s who of synthetic biology, including up-and-coming unicorns Pivot...

Automated Biology Is Now an Affordable Reality

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

To the scientists, researchers, founders and investors in the field, synthetic biology may excite because of its science-fiction quality technologies. It may excite because of its potential to solve some of the world’s...

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

Will programming a cell ever be as easy as programming an app?

The promised democratization of biology plays out as industry frontrunners consolidate early leads and bio-preneurs consider the sheer breadth of opportunity Today, anyone who can code can win in the internet economy...

A Next-Generation Infant Formula—The Closest To Mother’s Milk Yet—Made With Biology

Have your cake and eat it too, so long as they’re GMO: 5 Reasons GMO should be on your shopping list

Impossible Burger is a household name best recognized for its successful introduction of a plant-based burger that “bleeds” and has no animal hormones or antibiotics. But, there is another notable “first” for Impossible...

Despite Coronavirus, 85% Of Americans Are Thinking About Sustainability As Much As Or More Than Ever

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

View all posts

Press releases

Twist Bioscience Synthetic DNA Stores New Netflix Original Series ‘BIOHACKERS’

— World’s First Series Stored in DNA — August 20, 2020 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST) today announced that...

Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas

Bedford, Mass., Aug. 19, 2020 (GLOBE NEWSWIRE) — Conagen, a rapidly-growing Boston-based biotechnology firm, has established a novel and proprietary process for the scalable production of a non-GMO human milk...

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19...

Checkerspot Closes $36 Million Series B Round

Expanding its Innovation Platform to Create Performance Biomaterials Across Industries August 19, 2020 12:46 PM Eastern Daylight Time BERKELEY, Calif. & SALT LAKE CITY–(BUSINESS WIRE)–Checkerspot, Inc...

FMC Corporation Collaborates with Zymergen to Accelerate Discovery of Breakthrough Crop Protection Technologies

Leveraging largest metagenomic library in the world, this collaboration will speed development of cost-effective and higher-performing agricultural products PHILADELPHIA and EMERYVILLE, Calif., Aug. 20...

Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use

San Diego, Aug. 18, 2020 (GLOBE NEWSWIRE) — The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and...

LabShares Newton Announces Next Launch@LabShares Winner

Concerto Biosciences to Receive Free Lab Space worth $50,000 August 17, 2020 08:13 AM Eastern Daylight Time NEWTON, Mass.–(BUSINESS WIRE)–LabShares Newton, a shared office and laboratory incubator for...

Lygos Successfully Validates Novel Fermentation Process for Sustainable and Rare Cannabinoids

After rapid integration of NIH-funded Librede technology, company now focused on scaling to commercial quantities and launching new consumer products August 17, 2020 08:05 AM Eastern Daylight Time BERKELEY, Calif...

Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers

– First-in-class investigational, off-the-shelf immunotherapy utilizing AdenoVerse™ platform designed to activate the immune system to recognize and target HPV-positive solid tumors – – HPV-associated...

Kalion Inc. Receives NSF Phase II SBIR Grant to Develop Bio-based Glucaric Acid

MILTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) — Kalion Inc. (pronounced KAL-LEE-ON) has been awarded a National Science Foundation (NSF) Phase II Small Business Research (SBIR) grant for $746,822 to conduct...

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

− Transfer of Caribou’s novel microbial IP will enable new therapeutic opportunities for Novome − − License to CRISPR-Cas9 intellectual property controlled by Caribou will accelerate the development of preclinical...

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

Dartmouth-Hitchcock Health Researchers Evaluating Sherlock™ CRISPR SARS-CoV-2 Kit to Test Real-world Samples from Member Hospitals; Results Expected in Coming Weeks August 12, 2020 08:30 AM Eastern Daylight Time...

Featured

COVID-19 Resources

Editors' picks

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Automated Biology Is Now an Affordable Reality

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

Will programming a cell ever be as easy as programming an app?

A Next-Generation Infant Formula—The Closest To Mother’s Milk Yet—Made With Biology

Have your cake and eat it too, so long as they’re GMO: 5 Reasons GMO should be on your shopping list

Despite Coronavirus, 85% Of Americans Are Thinking About Sustainability As Much As Or More Than Ever

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Press releases

Twist Bioscience Synthetic DNA Stores New Netflix Original Series ‘BIOHACKERS’

Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Checkerspot Closes $36 Million Series B Round

FMC Corporation Collaborates with Zymergen to Accelerate Discovery of Breakthrough Crop Protection Technologies

Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use

LabShares Newton Announces Next Launch@LabShares Winner

Lygos Successfully Validates Novel Fermentation Process for Sustainable and Rare Cannabinoids

Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers

Kalion Inc. Receives NSF Phase II SBIR Grant to Develop Bio-based Glucaric Acid

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

News by topic

Agriculture

Health and medicine

Funding & investments

Biomanufacturing, chemicals & materials

Emerging technologies

Food and nutrition

Consumer goods

Energy & environment

Policy & public